Lam Research CEO Sells $26.8M in LRCX Stock Under 10b5-1 Plan
LAM RESEARCH CORP
Subscribe to track LRCX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Lam Research CEO Sells $26.8M in LRCX Stock Under 10b5-1 Plan
Company: LAM RESEARCH CORP (LRCX) Form: 4 | Filed: 2025-12-18 Significance: Low
Insider: ARCHER TIMOTHY Title: President and CEO | Relationship: Officer
Transaction: • Type: Sell • Shares: 163,300 • Price: $163.86 • Value: $26,758,338 • Owned After: 932,409 (Direct)
Key Insight: The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, reducing its significance as a signal of the insider's current sentiment.
Market Context: The transaction value represents a negligible 0.014% of Lam Research's $186.22B market cap.
Comprehensive Analysis
SEC Filing Analysis: LAM RESEARCH CORP (LRCX)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The President and CEO, Timothy Archer, sold $26.8 million worth of company stock following an option exercise, all executed under a pre-scheduled Rule 10b5-1 trading plan.
- Market Impact: The transaction is unlikely to have a material impact on the stock due to its small size relative to the company's market capitalization and its pre-planned nature.
Company Information
| Field | Value |
|---|---|
| Company | LAM RESEARCH CORP |
| Ticker Symbol | LRCX |
| CIK | 0000707549 |
| Industry | Special Industry Machinery, NEC [3559] |
Insider Information
| Field | Value |
|---|---|
| Name | ARCHER TIMOTHY |
| CIK | 0001343600 |
| Title/Position | President and CEO |
| Relationship | Officer |
Transaction Details
This filing reports multiple transactions, including an option exercise and subsequent sales. The analysis focuses on the aggregate sales.
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-17 |
| Transaction Code | S (Sale), M (Option Exercise) |
| Security Type | Common Stock |
| Shares Involved | 163,300 (Sold) |
| Price Per Share | $163.86 (Sale Price) |
| Total Value | $26,758,338 (Total Sale Value) |
| Shares Owned After | 932,409 (Directly) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $26,758,338 |
| % of Market Cap | 0.014% |
| Shares Transacted | 163,300 |
| % of Shares Outstanding | 0.013% |
| Post-Transaction Ownership | 932,409 shares (0.074% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a mega-cap company with a market capitalization of $186.22 billion, a $26.8 million transaction is considered routine and immaterial from a market perspective.
- Ownership Concentration: The sale represents a portion of the CEO's holdings, but he retains a substantial position of over 932,000 shares directly, plus additional indirect holdings. His ownership concentration remains low relative to the total shares outstanding.
- Dilution Impact: The transaction involved an exercise of options followed by a sale, which is cash-flow neutral to the company and has a negligible dilutive effect as the options were likely already factored into diluted share counts.
- Transaction Significance: The sale's value is less than 0.1% of the market cap and the shares sold are less than 0.1% of shares outstanding, placing it firmly in the 'Low' significance category.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale is pre-planned via a 10b5-1 plan, which decouples it from any immediate, non-public information the insider might possess. The size of the sale is insignificant relative to the company's scale and daily trading volume.
Volume & Sentiment
- Expected Volume Impact: Negligible. The transaction size is a small fraction of the typical daily trading volume for LRCX.
- Sentiment Indicator: Neutral. Automated sales under 10b5-1 plans are common for executive compensation and financial planning and are generally not interpreted as a bearish signal by sophisticated market participants.
Additional Context
Transaction Notes
- Special Circumstances: As noted in Footnote F1, all transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2025. This indicates the sales were scheduled months in advance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
